These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11873223)

  • 1. NICE guidelines unfair for Alzheimer's disease.
    Lowery K
    Br J Nurs; 2001 Nov 8-21; 10(20):1314. PubMed ID: 11873223
    [No Abstract]   [Full Text] [Related]  

  • 2. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
    Noble JM
    BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 5. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with mild Alzheimer's disease should have access to drugs, says draft NICE guidance.
    Kmietowicz Z
    BMJ; 2010 Oct; 341():c5562. PubMed ID: 20926475
    [No Abstract]   [Full Text] [Related]  

  • 7. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
    Storosum JG; van Zwieten-Boot BJ; Elferink AJ
    BMJ; 1999 Sep; 319(7210):642. PubMed ID: 10523096
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction. Alzheimer's disease: from research to practice.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():3. PubMed ID: 9731542
    [No Abstract]   [Full Text] [Related]  

  • 10. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
    Ihl R; Frölich L; Winblad B; Schneider L; Burns A; Möller HJ;
    World J Biol Psychiatry; 2011 Feb; 12(1):2-32. PubMed ID: 21288069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should cholinesterase inhibitors be used to treat Alzheimer's disease?
    Finucane TE; Gilstad JR
    Nat Clin Pract Neurol; 2006 Mar; 2(3):118-9. PubMed ID: 16932534
    [No Abstract]   [Full Text] [Related]  

  • 12. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Alzheimer's disease with acetylcholinesterase inhibitors].
    Dartigues JF; Poncet M
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F107. PubMed ID: 18680827
    [No Abstract]   [Full Text] [Related]  

  • 15. NICE says anti-dementia drugs should be used only for moderate Alzheimer's disease.
    Day M
    BMJ; 2006 Oct; 333(7572):774. PubMed ID: 17038731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aspects of the report of the IQWiG (Institute for Quality and Cost Effectiveness in Public Health) " Cholinesterase inhibitors in Alzheimer's dementia"].
    Gogol M; Lüttje D; Werner H
    Z Gerontol Geriatr; 2007 Jun; 40(3):192-4. PubMed ID: 17565437
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease.
    Small G; Bullock R
    Alzheimers Dement; 2011 Mar; 7(2):177-84. PubMed ID: 21056013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE to see the bigger picture.
    Lancet Neurol; 2006 Feb; 5(2):103. PubMed ID: 16426980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescribing policy with dementia drugs: the UK NICE experience.
    Dening T
    Maturitas; 2009 Oct; 64(2):59-60. PubMed ID: 19767159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.